Search
Search Results
##search.searchResults.foundPlural##
-
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3603PDF: 1595HTML: 11449Figures Haase: 172 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3289PDF: 1239HTML: 2187Fi.1 Gritti.Rambaldi: 181 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1318PDF: 782HTML: 3100 -
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1505PDF: 544HTML: 211 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
3795PDF: 1426HTML: 9169Untitled: 254Untitled: 158Untitled: 146Untitled: 143Untitled: 162Untitled: 315 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3416PDF: 2323HTML: 1401 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2703PDF: 810HTML: 6491Untitled: 204Untitled: 167Untitled: 163Untitled: 186 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4481PDF: 2692HTML: 2218 -
ANORECTAL PATHOLOGIES IN THE COURSE OF ACUTE LEUKAEMIAS: PREDICTIVE PARAMETERS Anorectal pathologies in leukemias
1116PDF: 673Html: 77 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1298PDF: 1263HTML: 77 -
-
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3140PDF: 1295HTML: 4102 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4222PDF: 1444HTML: 1528Untitled: 207 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3638PDF: 1404HTML: 455Figures . Eliassian: 198 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2169PDF: 851HTML: 1975Fig 1 Rossi: 151 -
Severe eosinophilia in a case of giardiasis
984PDF: 1485HTML: 402 -
COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA
2557PDF: 936HTML: 4682 -
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ
962PDF: 883Suppl. Files: 576HTML: 70 -
EFFECT OF FRESH VERSUS CRYOPRESERVED GRAFTS ON FEBRILE NEUTROPENIA AND INFECTIONS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: FACTORS DETERMINING MORTALITY. Fresh vs Frozen Grafts: Infection and Outcome
627PDF: 343HTML: 67 -
THE ROLE OF WHITE BLOOD CELL COUNT IN PERIANAL PATHOLOGIES: A RETROSPECTIVE ANALYSIS OF HEMATOLOGIC MALIGNANCIES Role of white blood cell count in perianal pathologies
2427PDF: 1731HTML: 218 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
1751PDF: 686HTML: 2082Untitled: 186Untitled: 137Untitled: 151Untitled: 137Untitled: 144Untitled: 160Untitled: 166 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
1938PDF: 770HTML: 194 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4175PDF: 1330HTML: 2022 -
CD48 AS A NOVEL EARLY BIOMARKER COMPLEMENTING PROCALCITONIN AND LACTATE FOR PREDICTING BACTEREMIA IN PEDIATRIC FEBRILE NEUTROPENIA: A PROSPECTIVE COHORT STUDY CD48 A NOVEL EARLY BIOMARKER PREDICTING BACTERIEMIA
720PDF: 447HTML: 86 -
Osteolytic bone lesions – A rare presentation of AML M6.
1918PDF: 1047HTML: 7898Untitled: 180 -
A STUDY ON THE EXPRESSION OF BCR-ABL TRANSCRIPT IN MIXED PHENOTYPE ACUTE LEUKEMIA (MPAL) CASES USING THE REVERSE TRANSCRIPTASE POLYMERASE REACTION ASSAY (RT-PCR) AND ITS CORRELATION WITH HEMATOLOGICAL REMISSION STATUS POST INITIAL INDUCTION THERAPY
1300PDF: 774HTML: 5015INSTITUTE PUBLICATION COMMITTEE APPROVAL: 140 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3103PDF: 741HTML: 2909Figure 1a and 1b: 132Figure 2: 135Figure 3: 157Figure 4: 141Figure 5: 143Tables 1-5: 139 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1849PDF: 701HTML: 677







